ITIH4 and infection: As examples, multiple studies have linked ADCC against gp120 with protection from infection in non-human primate (NHP) models [68–77]; with reduced risk of infection in the RV144 vaccine trial [78]; with decreased risk of mother-to-child HIV-1 transmission [79]; and lower viral loads during HIV disease progression [54, 80, 81].